MedTrace Logo

U.S. CTEPH Registry

NCT02429284 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 754

Last updated 2020-03-24

No results posted yet for this study

Summary

The U.S. CTEPH Registry is a multicenter, observational, U.S.-based study of the clinical course and treatment of patients diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH), WHO Group IV Classification for Pulmonary Hypertension. The mission of the Registry will be to promote a greater understanding of the prevalence, pathophysiology, evaluation, and treatment of patients with CTEPH through shared information, education, and collaborative investigation among pulmonary hypertension (PH) centers of excellence throughout the U.S.

Conditions

  • Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
  • Pulmonary Hypertension

Sponsors & Collaborators

Principal Investigators

  • Kim M Kerr, MD · University of California, San Diego

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2019-05-31
Completion
2019-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02429284 on ClinicalTrials.gov